Tavin L Tablets

Q1: What is Tavin-L (Lamivudine + Tenofovir) used for?

Tavin-L is a dual NRTI combination of Lamivudine and Tenofovir DF used as the NRTI backbone in HIV combination therapy. Combined with a third agent (INSTI, NNRTI, or PI), it provides effective HIV-1 suppression.

Q2: How do Lamivudine and Tenofovir work together?

Lamivudine (3TC) and Tenofovir DF are complementary NRTIs that inhibit HIV reverse transcriptase at different positions. Their synergistic activity provides robust dual NRTI suppression and a meaningful barrier to resistance.

Q3: How is Tavin-L taken?

Take once daily at a consistent time, with or without food. Never stop without consulting your HIV specialist. Consistent daily adherence is critical for preventing resistance.

Q4: Does Tavin-L treat hepatitis B?

Yes. Both Tenofovir and Lamivudine have anti-HBV activity, providing dual HIV/HBV suppression in co-infected patients. Never stop Tavin-L without maintaining HBV coverage to prevent severe hepatitis flares.

Q5: What are the most common side effects?

Nausea, diarrhea, headache, and fatigue are most common, particularly early in treatment. Long-term Tenofovir use may reduce bone mineral density and rarely cause kidney tubular dysfunction.

Q6: What kidney monitoring is required?

Serum creatinine, eGFR, and urine protein should be checked at baseline and every 6 months. Patients with eGFR <30 ml/min should not use TDF-containing regimens.

Q7: What serious side effects require emergency care?

Seek immediate care for: lactic acidosis (muscle pain, weakness, breathing difficulty), severe hepatotoxicity, or HBV hepatitis flare if treatment is stopped in co-infected patients.

Q8: Can Tavin-L be used during pregnancy?

Both Tenofovir and Lamivudine are included in HIV-in-pregnancy guidelines. The complete antiretroviral regimen during pregnancy should be managed jointly by HIV and obstetric specialists.

Q9: What monitoring is required during treatment?

CD4 count and viral load every 3–6 months. Renal function (creatinine, eGFR, phosphate) every 6 months. Bone density assessment if osteoporosis risk factors are present.

Q10: How does Tavin-L compare to FTC/TDF (Truvada equivalent)?

Lamivudine and Emtricitabine are pharmacologically similar NRTIs — both are cytidine analogues with comparable anti-HIV activity. Tavin-L is clinically equivalent to FTC/TDF as an NRTI backbone in most HIV regimens.

Q11: How should Tavin-L be stored?

Store at room temperature away from light and moisture. Keep in original packaging out of reach of children.

Q12: Do I need a prescription?

Yes. Tavin-L requires specialist HIV prescribing with baseline viral load, CD4, and renal function assessment.